Evidence map›Paper›PMID 35192371›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Reply to A. Kurreck et al and M.S. Copur et al.

Richard Adams, Richard Wilson, Louise Brown, Timothy Maughan

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Richard AdamsRichard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-3915-7243
Richard WilsonRichard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-8018-7730
Louise BrownRichard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-2827-6634
Timothy MaughanRichard Adams, MD, Centre for Trials Research Cardiff University and Velindre NHS Trust, Cardiff, Wales; Richard Wilson, PhD, Beatson Hospital, Glasgow, Scotland; Louise Brown, PhD, MRC Clinical Trials Unit at UCL, London, United Kingdom; and Timothy Maughan, MD, MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-0580-5065

Funding

Cancer Research UK 25350Medical Research Council G0701770Medical Research Council MC_UU_00004/01Medical Research Council MC_UU_00004/02Medical Research Council MC_UU_12023/20Medical Research Council MC_UU_12023/25
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35192371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.